| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0169-409X(01)00131-4 |
| P698 | PubMed publication ID | 11377808 |
| P2093 | author name string | Weissig V | |
| Torchilin VP | |||
| P2860 | cites work | Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure | Q24634002 |
| Mitochondrial gene therapy: an arena for the biomedical use of inteins | Q28143675 | ||
| Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy | Q28292821 | ||
| Mitochondrial diseases in man and mouse | Q29614555 | ||
| Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism | Q29616055 | ||
| Effects of the lipophilic biscation, bis-pyridinium oxime BP12, on bioenergetics and induction of permeability transition in isolated mitochondria | Q30828842 | ||
| Proteoliposomes colocalized with endogenous mitochondria in mouse fertilized egg. | Q30958663 | ||
| Assembly of functional proton-translocating ATPase complex in yeast mitochondria with cytoplasmically synthesized subunit 8, a polypeptide normally encoded within the organelle | Q33562514 | ||
| Abnormal DNA patterns in animal mitochondria: ethidium bromide-induced breakdown of closed circular DNA and conditions leading to oligomer accumulation | Q33711074 | ||
| Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil | Q33852989 | ||
| Drug delivery to mitochondria: the key to mitochondrial medicine | Q33853014 | ||
| Targeting of proteins to mitochondria | Q33908037 | ||
| Protein translocation pathways of the mitochondrion | Q33957089 | ||
| Human mitochondrial DNA diseases | Q34264417 | ||
| Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells | Q34264428 | ||
| Gene therapy by mitochondrial transfer | Q34264448 | ||
| An antigenomic strategy for treating heteroplasmic mtDNA disorders | Q34264454 | ||
| Targeting large molecules to mitochondria | Q34264476 | ||
| RNA delivery into mitochondria | Q34264482 | ||
| Towards mitochondrial gene therapy: DQAsomes as a strategy | Q34265156 | ||
| A different genetic code in human mitochondria | Q34280642 | ||
| Mitochondriotropic cationic vesicles: a strategy towards mitochondrial gene therapy | Q34315924 | ||
| Dequalinium, a topical antimicrobial agent, displays anticarcinoma activity based on selective mitochondrial accumulation | Q34335492 | ||
| DNA packaging induced by micellar aggregates: a novel in vitro DNA condensation system | Q34564392 | ||
| Monomolecular collapse of plasmid DNA into stable virus-like particles | Q35862312 | ||
| Intracellular fate of liposome-encapsulated DNA in mouse liver. Analysis using electron microscope autoradiography and subcellular fractionation | Q36495987 | ||
| Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells | Q37412636 | ||
| Organelle transformation: shoot first, ask questions later | Q37782985 | ||
| Archaeal lipids and their biotechnological applications | Q38177707 | ||
| Slip and leak in mitochondrial oxidative phosphorylation | Q38296693 | ||
| Apparent functional independence of the mitochondrial and nuclear transcription systems in cultured human cells. | Q38301258 | ||
| The emergence of clathrin-independent pinocytic pathways. | Q40380617 | ||
| Transfection of mitochondria: strategy towards a gene therapy of mitochondrial DNA diseases | Q40392500 | ||
| Self-assembling drugs: a new approach to biochemical modulation in cancer chemotherapy | Q40726389 | ||
| Recombinant adeno-associated virus vector-based gene transfer for defects in oxidative metabolism. | Q40846914 | ||
| Induction of apoptosis in WEHI 231 cells by cationic liposomes | Q40869288 | ||
| Peptide nucleic acid delivery to human mitochondria | Q40905811 | ||
| Induction of apoptosis in macrophages by cationic liposomes | Q40918986 | ||
| DQAsomes: a novel potential drug and gene delivery system made from Dequalinium | Q41055553 | ||
| Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids | Q41131488 | ||
| Pharmaceutical approach to somatic gene therapy | Q41257654 | ||
| Mitochondrial diseases and aging. | Q41378809 | ||
| Gene therapy of mitochondrial diseases using human cytoplasts | Q41382228 | ||
| Selective targeting of bioactive compounds to mitochondria | Q41570759 | ||
| Towards gene therapy of mitochondrial disorders | Q41717827 | ||
| Condensation of DNA by multivalent cations: Considerations on mechanism | Q43440600 | ||
| Probing mitochondria in living cells with rhodamine 123. | Q43563228 | ||
| Genetic vaccines: strategies for optimization | Q44233940 | ||
| Structural similarities between a mitochondrially encoded polypeptide and a family of prokaryotic respiratory toxins involved in plasmid maintenance suggest a novel mechanism for the evolutionary maintenance of mitochondrial DNA | Q44706941 | ||
| Processing of artificial peptide-DNA-conjugates by the mitochondrial intermediate peptidase (MIP). | Q45862392 | ||
| Cellular and molecular barriers to gene transfer by a cationic lipid | Q45868044 | ||
| Selective DNA release from DQAsome/DNA complexes at mitochondria-like membranes | Q45869262 | ||
| Modification of the mouse mitochondrial genome by insertion of an exogenous gene | Q45884340 | ||
| Cationic liposome-mediated transfection. | Q45997090 | ||
| Liposomes as agents of DNA transfer | Q46127415 | ||
| Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines | Q46313522 | ||
| Polyelectrolyte effects in DNA condensation by polyamines. | Q52436255 | ||
| The influence of respiration and ATP hydrolysis on the proton-electrochemical gradient across the inner membrane of rat-liver mitochondria as determined by ion distribution. | Q52887680 | ||
| Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies | Q59055292 | ||
| DNA-protein conjugates can enter mitochondria via the protein import pathway. | Q59060617 | ||
| Mechanism of Coupling of Oxidative Phosphorylation and the Membrane Potential of Mitochondria | Q59066915 | ||
| Effect of hypoxia and acidosis on the cytotoxicity of six metal(ligand)4(rhodamine-123), complexes at normal and hyperthermic temperatures | Q67880730 | ||
| Interaction of intravenously injected liposomes with mouse liver mitochondria. A fluorescence and electron microscopy study | Q69586664 | ||
| Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection | Q71099227 | ||
| Liposomes injected intravenously into mice associate with liver mitochondria | Q71420632 | ||
| Mechanism of inhibition of FaDu hypopharyngeal carcinoma cell growth by tetraphenylphosphonium chloride | Q72362306 | ||
| New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy | Q72370737 | ||
| Micellar properties and surface activity of some bolaform drugs in aqueous solution | Q72428089 | ||
| Introduction of plasmid DNA into isolated mitochondria by electroporation. A novel approach toward gene correction for mitochondrial disorders | Q73067691 | ||
| Induction of mitochondrial dysfunction and apoptosis in HeLa cells by bis-pyridinium oximes, a newly synthesized family of lipophilic biscations | Q73595624 | ||
| Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm | Q74316460 | ||
| Import of RNA into mitochondria | Q75292943 | ||
| Dequalinium vesicles form stable complexes with plasmid DNA which are protected from DNase attack | Q78074567 | ||
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrion | Q39572 |
| P304 | page(s) | 127-149 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Cationic bolasomes with delocalized charge centers as mitochondria-specific DNA delivery systems | |
| P478 | volume | 49 |
| Q36899668 | 2-N-Methyl modifications and SAR studies of manzamine A |
| Q42322592 | A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells. |
| Q38351743 | Bolaamphiphiles: a pharmaceutical review |
| Q46331885 | Carbon quantum dots with intrinsic mitochondrial targeting ability for mitochondria-based theranostics |
| Q41123555 | Covalent, Non-Covalent, Encapsulated Nanodrug Regulate the Fate of Intra- and Extracellular Trafficking: Impact on Cancer and Normal Cells. |
| Q40158054 | DNA delivery to the mitochondria sites using mitochondrial leader peptide conjugated polyethylenimine |
| Q44589785 | DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells |
| Q43698396 | DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria |
| Q35401809 | Design and synthesis of a mitochondria-targeting carrier for small molecule drugs. |
| Q59714942 | Development of Novel Peptides for Mitochondrial Drug Delivery: Amino Acids Featuring Delocalized Lipophilic Cations |
| Q37915391 | From serendipity to mitochondria-targeted nanocarriers |
| Q36688667 | Gene therapy of the other genome: the challenges of treating mitochondrial DNA defects |
| Q39114835 | Improved Targeting of Cancers with Nanotherapeutics |
| Q44326721 | Isothermic titration calorimetry to study CMCs of neutral surfactants and of the liposome-forming bolaamphiphile dequalinium |
| Q46494088 | Mitochondria-Targeted Agents: Mitochondriotropics, Mitochondriotoxics, and Mitocans |
| Q36918016 | Mitochondria-specific nanotechnology |
| Q90334182 | Multidisciplinary Approach to the Transfection of Plasmid DNA by a Nonviral Nanocarrier Based on a Gemini-Bolaamphiphilic Hybrid Lipid |
| Q39334978 | Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery |
| Q39953108 | Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel |
| Q64889373 | Nanoformulated ABT-199 to effectively target Bcl-2 at mitochondrial membrane alleviates airway inflammation by inducing apoptosis. |
| Q38165639 | Nanopreparations for organelle-specific delivery in cancer |
| Q35005702 | Optimizing the delivery systems of chimeric RNA.DNA oligonucleotides |
| Q34407663 | Pharmacologic rescue of an enzyme-trafficking defect in primary hyperoxaluria 1. |
| Q37587184 | Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet |
| Q36316672 | Targeted drug delivery to mammalian mitochondria in living cells |
| Q36934007 | Targeted polymeric therapeutic nanoparticles: design, development and clinical translation |
| Q34264476 | Targeting large molecules to mitochondria |
| Q26800890 | Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents |
| Q48360842 | pH-Responsive de-PEGylated nanoparticles based on triphenylphosphine-quercetin self-assemblies for mitochondria-targeted cancer therapy. |
Search more.